Tamara I. King

731 total citations
19 papers, 540 citations indexed

About

Tamara I. King is a scholar working on Pharmacology, Biochemistry and Organic Chemistry. According to data from OpenAlex, Tamara I. King has authored 19 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 13 papers in Biochemistry and 8 papers in Organic Chemistry. Recurrent topics in Tamara I. King's work include Alkaloids: synthesis and pharmacology (13 papers), Traditional and Medicinal Uses of Annonaceae (13 papers) and Chemical synthesis and alkaloids (8 papers). Tamara I. King is often cited by papers focused on Alkaloids: synthesis and pharmacology (13 papers), Traditional and Medicinal Uses of Annonaceae (13 papers) and Chemical synthesis and alkaloids (8 papers). Tamara I. King collaborates with scholars based in United States, Malaysia and Italy. Tamara I. King's co-authors include Christopher R. McCurdy, Abhisheak Sharma, Shyam H. Kamble, Francisco León, Bonnie A. Avery, Erin C. Berthold, Lance Richard McMahon, Raju S. Kanumuri, Surash Ramanathan and Nelson Jeng‐Yeou Chear and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Talanta.

In The Last Decade

Tamara I. King

19 papers receiving 514 citations

Peers

Countries citing papers authored by Tamara I. King

Since Specialization

Citations

This map shows the geographic impact of Tamara I. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamara I. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamara I. King more than expected).

Fields of papers citing papers by Tamara I. King

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamara I. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamara I. King. The network helps show where Tamara I. King may publish in the future.

Co-authorship network of co-authors of Tamara I. King

This figure shows the co-authorship network connecting the top 25 collaborators of Tamara I. King. A scholar is included among the top collaborators of Tamara I. King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamara I. King. Tamara I. King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Formation of multiple ion types during MALDI imaging mass spectrometry analysis of Mitragyna speciosa alkaloids in dosed rat brain tissue 2024 ·Talanta ·(unknown), (unknown), (unknown), Tamara I. King, Erin C. Berthold, Sushobhan Mukhopadhyay, Abhisheak Sharma, Christopher R. McCurdy, Boone M. Prentice	3
2	Pharmacokinetic and Pharmacodynamic Consequences of Cytochrome P450 3A Inhibition on Mitragynine Metabolism in Rats 2023 ·Journal of Pharmacology and Experimental Therapeutics ·Shyam H. Kamble, Samuel Obeng, Francisco León, Luis F. Restrepo, Tamara I. King, Erin C. Berthold, Raju S. Kanumuri, (unknown), (unknown), Avi Patel, (unknown), Aidan J. Hampson, Christopher R. McCurdy, Lance Richard McMahon, Jenny L. Wilkerson, Abhisheak Sharma, Takato Hiranita	9
3	Metabolism of Speciociliatine, an Overlooked Kratom Alkaloid for its Potential Pharmacological Effects 2022 ·The AAPS Journal ·Shyam H. Kamble, Erin C. Berthold, Raju S. Kanumuri, Tamara I. King, (unknown), Francisco León, Marco Mottinelli, Lance Richard McMahon, Christopher R. McCurdy, Abhisheak Sharma	15
4	hERG block potencies for 5 positive control drugs obtained per ICH E14/S7B Q&As best practices: Impact of recording temperature and drug loss 2022 ·Journal of Pharmacological and Toxicological Methods ·(unknown), Nicolas Thiebaud, (unknown), Serge Viatchenko‐Karpinski, (unknown), Tamara I. King, Murali K. Matta, Omnia A. Ismaiel, Vikram Patel, (unknown), José Vicente, Wendy Wu	7
5	Determination of five positive control drugs in hERG external solution (buffer) by LC-MS/MS to support in vitro hERG assay as recommended by ICH S7B 2022 ·Journal of Pharmacological and Toxicological Methods ·Tamara I. King, (unknown), (unknown), (unknown), (unknown), (unknown), Omnia A. Ismaiel, Wendy Wu, (unknown), Vikram Patel, Rodney Rouse, David G. Strauss, Murali K. Matta	3
6	Activity of Mitragyna speciosa (“Kratom”) Alkaloids at Serotonin Receptors 2021 ·Journal of Medicinal Chemistry ·Francisco León, Samuel Obeng, Marco Mottinelli, (unknown), Tamara I. King, Erin C. Berthold, Shyam H. Kamble, Luis F. Restrepo, Avi Patel, (unknown), (unknown), Takato Hiranita, Abhisheak Sharma, Aidan J. Hampson, Clinton E. Canal, Lance Richard McMahon, Christopher R. McCurdy	50
7	Oral Pharmacokinetics in Beagle Dogs of the Mitragynine Metabolite, 7-Hydroxymitragynine 2021 ·European Journal of Drug Metabolism and Pharmacokinetics ·Elizabeth A. Maxwell, Tamara I. King, Shyam H. Kamble, Raju S. Kanumuri, Erin C. Berthold, Francisco León, Aidan J. Hampson, Lance Richard McMahon, Christopher R. McCurdy, Abhisheak Sharma	11
8	Pharmacokinetics of Eleven Kratom Alkaloids Following an Oral Dose of Either Traditional or Commercial Kratom Products in Rats 2021 ·Journal of Natural Products ·Shyam H. Kamble, Erin C. Berthold, Tamara I. King, Raju S. Kanumuri, (unknown), (unknown), Francisco León, Abhisheak Sharma, Lance Richard McMahon, Bonnie A. Avery, Christopher R. McCurdy	36
9	Discovery of a Highly Selective Sigma-2 Receptor Ligand, 1-(4-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-3-methyl-1H-benzo[d]imidazol-2(3H)-one (CM398), with Drug-Like Properties and Antinociceptive Effects In Vivo 2020 ·The AAPS Journal ·Sebastiano Intagliata, Abhisheak Sharma, Tamara I. King, Christophe Mésangeau, Michael J. Seminerio, Frederick T. Chin, Lisa Wilson, Rae R. Matsumoto, Jay P. McLaughlin, Bonnie A. Avery, Christopher R. McCurdy	38
10	Bioanalytical method development and pharmacokinetics of MCI-92, a sigma-1 receptor ligand 2020 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown), Shyam H. Kamble, Raju S. Kanumuri, Tamara I. King, Erin C. Berthold, Sebastiano Intagliata, Abhisheak Sharma, Christopher R. McCurdy	4
11	Preclinical pharmacokinetic study of speciociliatine, a kratom alkaloid, in rats using an UPLC-MS/MS method 2020 ·Journal of Pharmaceutical and Biomedical Analysis ·Erin C. Berthold, Shyam H. Kamble, Raju S. Kanumuri, Tamara I. King, (unknown), Abhisheak Sharma, Francisco León, Bonnie A. Avery, Lance Richard McMahon, Christopher R. McCurdy	16
12	Regulatory sampling of industrial hemp plant samples (Cannabis sativa L.) using UPLC-MS/MS method for detection and quantification of twelve cannabinoids 2020 ·Journal of Cannabis Research ·Erin C. Berthold, Rui Yang, Abhisheak Sharma, Shyam H. Kamble, Raju S. Kanumuri, Tamara I. King, (unknown), Joshua H. Freeman, Zachary Brym, Bonnie A. Avery, Christopher R. McCurdy	15
13	Pharmacokinetics and Safety of Mitragynine in Beagle Dogs 2020 ·Planta Medica ·Elizabeth A. Maxwell, Tamara I. King, Shyam H. Kamble, Raju S. Kanumuri, Erin C. Berthold, Francisco León, Bonnie A. Avery, Lance Richard McMahon, Christopher R. McCurdy, Abhisheak Sharma	24
14	Metabolism of a Kratom Alkaloid Metabolite in Human Plasma Increases Its Opioid Potency and Efficacy 2020 ·ACS Pharmacology & Translational Science ·Shyam H. Kamble, Francisco León, Tamara I. King, Erin C. Berthold, (unknown), Raju S. Kanumuri, Aidan J. Hampson, Abhisheak Sharma, Bonnie A. Avery, Lance Richard McMahon, Christopher R. McCurdy	50
15	Exploration of cytochrome P450 inhibition mediated drug-drug interaction potential of kratom alkaloids 2019 ·Toxicology Letters ·Shyam H. Kamble, Abhisheak Sharma, Tamara I. King, Erin C. Berthold, Francisco León, (unknown), Raju S. Kanumuri, Lance Richard McMahon, Christopher R. McCurdy, Bonnie A. Avery	48
16	Bioanalytical method development and validation of corynantheidine, a kratom alkaloid, using UPLC-MS/MS, and its application to preclinical pharmacokinetic studies 2019 ·Journal of Pharmaceutical and Biomedical Analysis ·Tamara I. King, Abhisheak Sharma, Shyam H. Kamble, Francisco León, Erin C. Berthold, (unknown), (unknown), Boone M. Prentice, Lance Richard McMahon, Christopher R. McCurdy, Bonnie A. Avery	20
17	Simultaneous quantification of ten key Kratom alkaloids in Mitragyna speciosa leaf extracts and commercial products by ultra‐performance liquid chromatography−tandem mass spectrometry 2019 ·Drug Testing and Analysis ·Abhisheak Sharma, Shyam H. Kamble, Francisco León, Nelson Jeng‐Yeou Chear, Tamara I. King, Erin C. Berthold, Surash Ramanathan, Christopher R. McCurdy, Bonnie A. Avery	77
18	Metabolite profiling and identification of enzymes responsible for the metabolism of mitragynine, the major alkaloid of Mitragyna speciosa (kratom) 2018 ·Xenobiotica ·Shyam H. Kamble, Abhisheak Sharma, Tamara I. King, Francisco León, Christopher R. McCurdy, Bonnie A. Avery	73
19	Photostability Issues in Pharmaceutical Dosage Forms and Photostabilization 2017 ·AAPS PharmSciTech ·Karthik Yadav Janga, Tamara I. King, Nan Ji, Sandeep Sarabu, (unknown), (unknown), (unknown), Michael A. Repka, S. Narasimha Murthy	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact